$INV

Innventure, Inc.

1
0
0

No SEC Form 4 filings for $INV in the last 30 days.

Med

Innventure (INV) Q4 2025 Earnings Transcript

Innventure (INV) reported 2025 revenue of $2.1m vs. $1.2m in 2024, driven by Accelsius and AeroFlexx. Accelsius delivered $1.6m revenue (vs. $0.3m) and secured $50m+ in new Q1 bookings; Accelsius Series B closed at a ~$665m post-money valuation. Management expects Accelsius to be cash-flow positive by year-end. Cash rose to $65.4m; adjusted EBITDA loss was $78.8m.

Innventure (NASDAQ: INV) executive chair granted 154,829 milestone shares

Innventure's Executive Chairman, Michael Otworth, has been granted 154,829 shares of common stock at no cash cost. This award was provided in connection with achieving a milestone outlined in the company's Business Combination Agreement. Following this transaction, Otworth now directly holds 3,550,087 shares of Innventure common stock.

News on $INV